Status:
COMPLETED
An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers
Lead Sponsor:
Neothetics, Inc
Conditions:
Subcutaneous Adipose Tissue Reduction
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.
Eligibility Criteria
Inclusion
- Male and non pregnant female
- 18-55 years old
- Sufficient abdominal fat for injections
- Signed informed consent
Exclusion
- Known hypersensitivity to study drugs
- Treatment with an investigational agent within 30 days before first dose
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00918606
Start Date
February 1 2009
End Date
June 1 2009
Last Update
March 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baltimore, Maryland, United States